Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16+
SponsorKasr El Aini Hospital
About this trial
The goal of this clinical trial is to learn Labroplasty using the long head of biceps tendon works to patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (\<20%) and thinned or deficient anterior labrum .The main questions it aims to answer are:
Does Labroplasty using the long head of biceps improve the functional and radiological outcomes in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss?
Participants will:
undergo arthroscopic labroplasty using the long head of biceps tendon Visit the clinic regularly for checkup and followup undergo MRI at 6 months to check radiological outcome
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with recurrent anterior shoulder instability with one or more events of anterior shoulder dislocation.
Franceschi types 2 and 3 labral defects
subcritical glenoid bone loss <20%
positive anterior shoulder apprehension
Disqualifiers
Critical glenoid bones loss >20%
Franceschi type 1 labral defect
concomitant long head of biceps tendon pathology
multidirectional instability
Trial design
Design model
Single group
Treatments tested in this trial
Arthroscopic Labroplasty using long head of biceps tendon
Procedure/SurgeryArthroscopic All-inside labral reconstruction using the long head of biceps tendon
Treatment groups
21 Participants
are divided into 1 treatment groupGroup A: patients with recurrent anterior shoulder instability with subcritical glenoid bone lossExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Modified Rowe score postoperative
Time frame
Assessed preoperative , then at 6 months and 12 months postoperativeSecondary outcomes
1
Constant shoulder score
Time frame
assessed preoperative , then at 6 months and 12 months postopertiveSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov